| A type III effector antagonizes death receptor signalling during bacterial gut infection JS Pearson, C Giogha, SY Ong, CL Kennedy, M Kelly, KS Robinson, ... Nature 501 (7466), 247-251, 2013 | 290 | 2013 |
| EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation JS Pearson, C Giogha, S Mühlen, U Nachbur, CLL Pham, Y Zhang, ... Nature microbiology 2 (4), 1-10, 2017 | 192 | 2017 |
| The Genetics of Enteropathogenic Escherichia coli Virulence JS Pearson, C Giogha, T Wong Fok Lung, EL Hartland Annual review of genetics 50 (1), 493-513, 2016 | 87 | 2016 |
| The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD) NE Scott, C Giogha, GL Pollock, CL Kennedy, AI Webb, NA Williamson, ... Journal of Biological Chemistry 292 (42), 17337-17350, 2017 | 59 | 2017 |
| Inhibition of death receptor signaling by bacterial gut pathogens C Giogha, TWF Lung, JS Pearson, EL Hartland Cytokine & growth factor reviews 25 (2), 235-243, 2014 | 55 | 2014 |
| SseK3 Is a Salmonella Effector That Binds TRIM32 and Modulates the Host’s NF-κB Signalling Activity Z Yang, A Soderholm, TWF Lung, C Giogha, MM Hill, NF Brown, ... PloS one 10 (9), e0138529, 2015 | 54 | 2015 |
| Salmonella effectors SseK1 and SseK3 target death domain proteins in the TNF and TRAIL signaling pathways JPM Newson, NE Scott, IYW Chung, TWF Lung, C Giogha, J Gan, ... Molecular & Cellular Proteomics 18 (6), 1138-1156, 2019 | 51 | 2019 |
| Distinct roles of the antiapoptotic effectors NleB and NleF from enteropathogenic Escherichia coli GL Pollock, CVL Oates, C Giogha, T Wong Fok Lung, SY Ong, ... Infection and immunity 85 (4), 10.1128/iai. 01071-16, 2017 | 38 | 2017 |
| The type III effector NleD from enteropathogenic Escherichia coli differentiates between host substrates p38 and JNK K Creuzburg, C Giogha, T Wong Fok Lung, NE Scott, S Mühlen, ... Infection and immunity 85 (2), 10.1128/iai. 00620-16, 2017 | 27 | 2017 |
| Mutagenesis and functional analysis of the bacterial arginine glycosyltransferase effector NleB1 from enteropathogenic Escherichia coli T Wong Fok Lung, C Giogha, K Creuzburg, SY Ong, GL Pollock, Y Zhang, ... Infection and immunity 84 (5), 1346-1360, 2016 | 22 | 2016 |
| Substrate recognition by the zinc metalloprotease effector NleC from enteropathogenic Escherichia coli C Giogha, T Wong Fok Lung, S Mühlen, JS Pearson, EL Hartland Cellular Microbiology 17 (12), 1766-1778, 2015 | 22 | 2015 |
| The Salmonella Effector SseK3 Targets Small Rab GTPases J Gan, NE Scott, JPM Newson, RR Wibawa, T Wong Fok Lung, ... Frontiers in cellular and infection microbiology 10, 419, 2020 | 20 | 2020 |
| Molecular mechanisms employed by enteric bacterial pathogens to antagonise host innate immunity J Gan, C Giogha, EL Hartland Current Opinion in Microbiology 59, 58-64, 2021 | 15 | 2021 |
| NleB2 from enteropathogenic Escherichia coli is a novel arginine-glucose transferase effector C Giogha, NE Scott, T Wong Fok Lung, GL Pollock, M Harper, ... PLoS pathogens 17 (6), e1009658, 2021 | 12 | 2021 |
| EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation. Nat Microbiol 2: 16258 JS Pearson, C Giogha, S Muhlen, U Nachbur, CL Pham, Y Zhang, ... | 12 | 2016 |
| Manipulation of epithelial cell architecture by the bacterial pathogens Listeria and Shigella EL Hartland, D Ghosal, C Giogha Current Opinion in Cell Biology 79, 102131, 2022 | 10 | 2022 |
| Targeting of microvillus protein Eps8 by the NleH effector kinases from enteropathogenic E. coli GL Pollock, AM Grishin, C Giogha, J Gan, CV Oates, PJ McMillan, I Gaeta, ... Proceedings of the National Academy of Sciences 119 (34), e2204332119, 2022 | 8 | 2022 |
| The broccoli-derived antioxidant sulforaphane changes the growth of gastrointestinal microbiota, allowing for the production of anti-inflammatory metabolites SA Marshall, RB Young, JM Lewis, EL Rutten, J Gould, CK Barlow, ... Journal of Functional Foods 107, 105645, 2023 | 6 | 2023 |
| Sugar fix keeps RIPK3 at bay C Giogha, KE Lawlor Immunity 50 (3), 539-541, 2019 | 4 | 2019 |
| Shigella shuts down the pyrop-technic show C Giogha, JS Pearson Cell Host & Microbe 29 (10), 1473-1476, 2021 | 2 | 2021 |
